Chronix Biomedical Announces Multiple Poster Presentations at American Society of Clinical Oncology 2013
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, announces that four research abstracts highlighting the Company’s cell-free DNA technology for real-time cancer detection will be presented at the American Society of Clinical Oncology Annual Meeting 2013 (ASCO 2013) being held May 31 through June 4, 2013 at the McCormick Place Convention Center in Chicago. The abstracts highlight studies performed together with the MD Anderson Cancer Center in Houston, the Institute of Veterinary Medicine in Göttingen, Germany and the University of Toronto.
Help employers find you! Check out all the jobs and post your resume.
Chronix Biomedical, Inc., a developer of blood-based molecular diagnostics, announces that four research abstracts highlighting the Company’s cell-free DNA technology for real-time cancer detection will be presented at the American Society of Clinical Oncology Annual Meeting 2013 (ASCO 2013) being held May 31 through June 4, 2013 at the McCormick Place Convention Center in Chicago. The abstracts highlight studies performed together with the MD Anderson Cancer Center in Houston, the Institute of Veterinary Medicine in Göttingen, Germany and the University of Toronto.
Help employers find you! Check out all the jobs and post your resume.